FRANKLIN LAKES, N.J., July 19, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health ...

This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring and ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...

Nearly one in five smart pump customers say they would not buy their current pump again, with one exception, according to a new report from healthcare market research firm KLAS. The recent survey ...

FRANKLIN LAKES, N.J., Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH ...

(RTTNews) - Shares of Becton, Dickinson and Company (BDX) gained 5% in the extended trading session on Friday after the medical technology company announced that the updated BD Alaris Infusion System ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

The new solutions from CareFusion include three applications in its Alaris Connectivity Services portfolio, part of the CareFusion Coordination Engine, to enable clinicians to pre-populate infusion ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...